Sanofi India appoints Rachid Ayari as Interim MD
Mumbai: Sanofi India has appointed Rachid Ayari as its Interim Managing Director, while continuing in his current role as Chief Financial Officer (CFO). Ayari will hold the dual role for a six-month term starting July 21, 2025, or until a permanent MD is named, whichever is earlier.
The appointment follows the cessation of Rodolfo Hrosz as the Managing Director of the Company on 30th April 2025.
"We wish to inform you that upon the recommendation of the Nomination and Remuneration Committee and subject to approval of the Shareholders, the Board of Directors have approved the appointment of Mr. Rachid Ayari (DIN: 10408699) as the Interim Managing Director of the Company, in addition to his current role as the Chief Financial Officer of the Company, for a term of 6 months from 21st July 2025 to 20th January 2026 or until a Permanent Managing Director is appointed, whichever is earlier," Sanofi India stated in a BSE filing.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.